Associated Papers
Neurodevelopmental Implications Underpinning Hereditary Spastic Paraplegia.
Zhi Y et al.
Cns Neuroscience & Therapeutics, 2025
39932116 (PubMed )
Supplement: CNS-31-e70260-s001.xlsx › SPG11
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K.
Xu J et al.
European Journal of Neurology, 2024
39315749 (PubMed )
Supplement: ENE-31-e16473-s001.xlsx › Table_S2
Pathogenic PSEN1 Glu184Gly Mutation in a Family from Thailand with Probable Autosomal Dominant Early Onset Alzheimer's Disease.
Senanarong V et al.
Diagnostics (basel, Switzerland), 2020
32121568 (PubMed )
Supplement: diagnostics-10-00135-s001.pdf
Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.
Giau VV et al.
Scientific Reports, 2019
31182772 (PubMed )
Supplement: 41598_2019_44848_MOESM1_ESM.pdf
Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease.
Giau VV et al.
International Journal of Molecular Sciences, 2019
30917570 (PubMed )
Supplement: ijms-20-01514-s001.pdf
Two novel mutations in the SPG11 gene causing hereditary spastic paraplegia associated with thin corpus callosum.
Zhang SS et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2008
Select a paper to view details